反応式
[C:1]([O:10]C1C=CC=CC=1)(=O)[C:2]1[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=1)[OH:4].[NH2:17][C:18]1[CH:23]=[CH:22][C:21]([CH3:24])=[CH:20][CH:19]=1>>[CH3:24][C:21]1[CH:22]=[CH:23][C:18]([NH:17][C:1](=[O:10])[C:2]2[C:3](=[CH:5][CH:6]=[CH:7][CH:8]=2)[OH:4])=[CH:19][CH:20]=1参加物
3
実験手順
The 4′-methyl-salicylanilide was prepared by condensing phenyl salicylate with 4-toluidine then purified as described in Example 2a. A ligand mixture was then prepared from 4′-methyl-salicylanilide and binaphthol using the procedure described in Example 5a. 31P NMR (121.77 MHz): several peaks between 117.1-117.8 ppm.
後処理
- customthen purified
- customA ligand mixture was then prepared from 4′-methyl-salicylanilide and binaphthol using the procedure
出典と根拠
- ORDレコード
- ord-fc21bdecdfb54a22b3196ecf9c212560
- 出典データセット
- uspto-grants-2003_12
- 特許番号
- US06664427B1
関連ノート
読み込み中…